1202759-89-4 Usage
General Description
[3-(2-chloro-5-fluoro-pyrimidin-4-ylamino)-phenyl]-carbamic acid tert-butyl ester is a chemical compound with the molecular formula C16H18ClFN4O2. It is a tert-butyl ester derivative of [3-(2-chloro-5-fluoro-pyrimidin-4-ylamino)-phenyl]-carbamic acid, and it is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. The compound is known for its potential as an anticancer agent, and it exhibits inhibitory effects on certain enzymes involved in cancer cell growth. Additionally, it is also used as a building block for the preparation of novel heterocyclic compounds with pharmacological potential. Due to its versatile and important role in medicinal chemistry, research and development efforts are ongoing to explore the full potential of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 1202759-89-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,7,5 and 9 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1202759-89:
(9*1)+(8*2)+(7*0)+(6*2)+(5*7)+(4*5)+(3*9)+(2*8)+(1*9)=144
144 % 10 = 4
So 1202759-89-4 is a valid CAS Registry Number.
1202759-89-4Relevant articles and documents
HETEROARYL COMPOUNDS AND USES THEREOF
-
Paragraph 0200-0202, (2016/02/20)
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same. Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful for treating a variety of diseases, disorders or conditions, associated with abnormal cellular responses triggered by protein kinase-mediated events. Compounds provided by this invention are also useful for the study of kinases in biological and pathological phenoma, the study of intracellular signal transduction pathways mediated by such kinases and the comparative evaluation of new kinase inhibitors.
HETEROARYL COMPOUNDS AND USES THEREOF
-
, (2014/07/08)
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.
HETEROARYL COMPOUNDS AND USES THEREOF
-
Page/Page column 190; 191, (2010/01/30)
The present invention provides inhibitors of protein kinases of formula I-a and I-b, pharmaceutically acceptable compositions thereof, and methods of using the same.
